$2.48T
Total marketcap
$204.81B
Total volume
BTC 50.08%     ETH 15.66%
Dominance

Revolution Medicines RVMD Stock

30.94 USD {{ price }} -2.796102% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
5.1B USD
LOW - HIGH [24H]
30.86 - 32.05 USD
VOLUME [24H]
2.22M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-3.86 USD

Revolution Medicines Price Chart

Revolution Medicines RVMD Financial and Trading Overview

Revolution Medicines stock price 30.94 USD
Previous Close 25.25 USD
Open 25.18 USD
Bid 0 USD x 900
Ask 0 USD x 1200
Day's Range 24.44 - 25.62 USD
52 Week Range 16.79 - 31.37 USD
Volume 721.94K USD
Avg. Volume 913.78K USD
Market Cap 2.67B USD
Beta (5Y Monthly) 1.443588
PE Ratio (TTM) N/A
EPS (TTM) -3.86 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 31 USD

RVMD Valuation Measures

Enterprise Value 1.83B USD
Trailing P/E N/A
Forward P/E -6.963989
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 76.766685
Price/Book (mrq) 2.8064299
Enterprise Value/Revenue 52.462
Enterprise Value/EBITDA -6.734

Trading Information

Revolution Medicines Stock Price History

Beta (5Y Monthly) 1.443588
52-Week Change 39.58%
S&P500 52-Week Change 20.43%
52 Week High 31.37 USD
52 Week Low 16.79 USD
50-Day Moving Average 24.46 USD
200-Day Moving Average 22.95 USD

RVMD Share Statistics

Avg. Volume (3 month) 913.78K USD
Avg. Daily Volume (10-Days) 1.09M USD
Shares Outstanding 106.31M
Float 99.12M
Short Ratio 14.31
% Held by Insiders 1.72%
% Held by Institutions 84.85%
Shares Short 10.37M
Short % of Float 10.34%
Short % of Shares Outstanding 9.75%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -791.26%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -19.61%
Return on Equity (ttm) -34.47%

Income Statement

Revenue (ttm) 34.82M USD
Revenue Per Share (ttm) 0.41 USD
Quarterly Revenue Growth (yoy) -7.39%
Gross Profit (ttm) -217693000 USD
EBITDA -271241984 USD
Net Income Avi to Common (ttm) -259156000 USD
Diluted EPS (ttm) -3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 909.8M USD
Total Cash Per Share (mrq) 8.56 USD
Total Debt (mrq) 63.6M USD
Total Debt/Equity (mrq) 6.68 USD
Current Ratio (mrq) 16.889
Book Value Per Share (mrq) 8.958

Cash Flow Statement

Operating Cash Flow (ttm) -231632000 USD
Levered Free Cash Flow (ttm) -138491376 USD

Profile of Revolution Medicines

Country United States
State CA
City Redwood City
Address 700 Saginaw Drive
ZIP 94063
Phone 650 481 6801
Website https://www.revmed.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 259

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a tri-complex inhibitor of KRASG12C(ON) and KRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Q&A For Revolution Medicines Stock

What is a current RVMD stock price?

Revolution Medicines RVMD stock price today per share is 30.94 USD.

How to purchase Revolution Medicines stock?

You can buy RVMD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Revolution Medicines?

The stock symbol or ticker of Revolution Medicines is RVMD.

Which industry does the Revolution Medicines company belong to?

The Revolution Medicines industry is Biotechnology.

How many shares does Revolution Medicines have in circulation?

The max supply of Revolution Medicines shares is 164.69M.

What is Revolution Medicines Price to Earnings Ratio (PE Ratio)?

Revolution Medicines PE Ratio is now.

What was Revolution Medicines earnings per share over the trailing 12 months (TTM)?

Revolution Medicines EPS is -3.86 USD over the trailing 12 months.

Which sector does the Revolution Medicines company belong to?

The Revolution Medicines sector is Healthcare.

Revolution Medicines RVMD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD